Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

18.73 +1.86 (+10.99%)
Streaming Delayed Price Updated: 3:10 PM EDT, May 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,025,069
Open 17.30
Bid (Size) 18.73 (47)
Ask (Size) 18.74 (4)
Prev. Close 16.88
Today's Range 17.24 - 19.13
52wk Range 5.650 - 20.11
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A New Name in Weight Loss Drugs
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option. 
Via The Motley Fool
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights. 
Via The Motley Fool

Performance

YTD
+94.35%
+94.35%
1 Month
+51.82%
+51.82%
3 Month
+96.80%
+96.80%
6 Month
+127.92%
+127.92%
1 Year
+107.48%
+107.48%

More News

Read More
The Ultimate Growth Stock to Buy With $20 Right Now
Via The Motley Fool
7 Stocks to Dominate in the Next Economic Upturn
Via InvestorPlace
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
Via InvestorPlace
Navigating 10 Analyst Ratings For Hims & Hers Health
Via Benzinga
Hims & Hers Is Changing the Game
Via The Motley Fool
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
The Growth Stock Shuffle: 2 to Ditch and 1 to Own
Via InvestorPlace
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Via Benzinga
Topics ETFs
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next
Via Benzinga
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
Via InvestorPlace
Tech Surge Boosts Nasdaq To Record Highs
Via Talk Markets
Topics Stocks
Exposures US Equities
Is Hims & Hers Health Stock a Buy?
Via The Motley Fool
Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
Via Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
Via Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Via Benzinga
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
From Hims & Hers
Via Business Wire
Stock Market Mayhem: 3 Companies Ready to Shake Things Up
Via InvestorPlace
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
From Hims & Hers
Via Business Wire
3 Stocks That Suddenly Drew in Options Traders
Via MarketBeat
5 Medical Info Systems Stocks To Buy For Stable Returns
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.